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Recent trends in incidence of and mortality from breast, ovarian and
endometrial cancers in England and Wales and their relation to changing
fertility and oral contraceptive use
I dos Santos Silva and AJ Swerdlow
Epidemiological Monitoring Unit, Department ofEpidemiology and Population Sciences, London School ofHygiene and Tropical
Medicine, Keppel Street, London WCIE 7HT, UK.
Summary Reproductive-related factors play a major role in the aetiology of cancers of the breast, ovary and
endometrium. Pregnancy history influences the risk of each of these cancers, and oral contraceptive use
modifies the risks of ovarian and endometrial cancers, although its effect on breast cancer risk is less certain.
We analysed recent time trends in the incidence and mortality of these cancers in England and Wales and
assessed whether they can be explained by changes in fertility and oral contraceptive use. During 1962-87,
there were significant increases in the overall incidence of breast cancer (0.95% increase per annum) and
ovarian cancer (0.76% per annum) but little increase in endometrial cancer (0.13% per annum). At young ages
incidence of each of the cancers has declined in recent years, whereas at older ages there have been substantial
increases. Mortality data show similar time trends. In analyses by birth cohort, incidence of each of the
cancers increased steeply for successive cohorts born before the turn of the century, and more slowly for
cohorts thereafter, reaching a maximum for those born in the 1920s, and decreased for those born subse-
quently. The increases in incidence for women born before the turn of the century paralleled marked declines
in their fertility. The fall in risk for women born after the 1920s was not accompanied by significant increases
in their fertility, but coincided with the introduction and increase in use of oral contraceptives. For ovarian
and endometrial cancers this accords with strong evidence from person-based studies of the protective effect of
oral contraceptives. For breast cancer, the reasons for the recent decline are not clear. It would accord with
recent suggestions of a long-term protective effect of oral contraceptives, on which further studies are needed.
It is also possible, however, that changes in other risk factors such as dietary fat intake and menarcheal age
might have contributed to the recent declines in the risk of these cancers.
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Cancers of the breast, endometrium and ovary are the major
hormone-dependent cancers in women. Together they
accounted for 32.9% of all female cancer registrations and
28.9% of all female cancer deaths in England and Wales in
1968-85 (Swerdlow and dos Santos Silva, 1993).
A woman's reproductive history plays an important role in
the risk of these cancers. Studies have consistently shown a
higher risk of endometrial (Elwood et al., 1977) and ovarian
cancer (The Centers for Disease Control, 1983) in nulliparous
than parous women, and an inverse relationship with parity.
The risks of these cancers are also reduced by an early age at
menopause (Elwood et al., 1977; Hildreth et al., 1981), and
some studies, but not all, have also found a late age at
menarche to be protective (Elwood et al., 1977; Booth, 1991).
Early menarche, late first full-term pregnancy and late meno-
pause are the major known risk factors for breast cancer
(Pike et al., 1983). A woman's risk of breast cancer increases
with age at first full-term pregnancy; the risk in women first
bearing a child before age 20 is estimated to be one-third that
of women first bearing a child after age 34, after which the
risk associated with first births exceeds that of nulliparity
(MacMahon et al., 1970).
There is also consistent evidence that the use of combined
oral contraceptives has a sizeable protective effect against
epithelial ovarian cancer and endometrial cancer. The major-
ity of studies show that pill use does not cause any overall
increase in risk of female breast cancer (Malone et al., 1993),
but there is concern about the effect of early use. Recently, it
has been suggested that oral contraceptive use might have a
dual effect on breast cancer risks with an early transitory
adverse effect and a long-term protective effect (Beral and
Reeves, 1993).
In this paper, we analyse trends in the incidence and
mortality of breast, ovarian and endometrial cancers in En-
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gland and Wales, and assess whether these trends can be
explained by changes in childbearing pattern and oral contra-
ceptive use.
Materials and methods
Cancer registration has existed at a national level in England
and Wales since 1945, and since 1962 it has had complete
national geographic coverage. Registration is carried out by
regional registries, which send data to the national registry at
the Office of Population Censuses and Surveys (OPCS),
which validates, analyses and publishes the data. Notification
of cancers is voluntary, but completeness has improved since
the scheme started, and it has probably been about 90%
since 1971 (Swerdlow et al., 1993). Data on cause of death
have been collected since 1837 and death registration has
been virtually complete since 1926 (Swerdlow, 1987).
Site of primary malignancy has been coded in the OPCS
files according to the Seventh Revision of the International
Classification ofDiseases (ICD) (World Health Organization,
1957) for 1962-67 data, the Eighth Revision (WHO, 1967)
for 1968-78 and the Ninth Revision (WHO, 1977) for data
from 1979 onwards. We extracted from the national cancer
registry files data on all cancers incident 1962-87 in women
resident in England and Wales with primary site of malig-
nancy; breast (ICD-7, 170; ICD-8 and ICD-9, 174), ovary
(ICD-7, 175.0; ICD-8 and ICD-9, 183.0) and endometrium
(ICD-7, 172, 174; ICD-8, 182; ICD-9, 179, 182). This period
was chosen because 1962 was the year when the cancer
registration scheme achieved national coverage and 1987 was
the most recent year for which the data were complete at the
time of extraction from the national cancer registration files.
We also extracted from OPCS files data on mortality from
these cancer sites in 1962-91. Annual population estimates
for England and Wales in 1962-91 by single year ofage were
supplied by OPCS, which conducts national censuses everyBreast, ovarian and endometrial cancertrends
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10 years and calculates population estimates for intercensal
years.
To assess secular trends, we fitted a Poisson regression
model (Breslow and Day, 1987). Results are reported as
average annual percentage changes in incidence and mortality
rates during the period. Trends in cancer incidence and
mortality were analysed for all ages combined, and also
separately for ages under 45 and 45 and over, to assess
whether trends and relationships to risk factors differed for
pre- and post-menopausal women. We also conducted some
analyses by 5 year age group.
To compare risks by birth cohort, age-standardised cohort
registration and mortality ratios (SCRRs and SCMRs) were
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Figure 1 Incidence rates of breast (a), ovarian (b) and endome-
trial (c) cancers in women at selected ages, expressed as propor-
tions of the corresponding 1962-66 rates. England and Wales,
1962-87.
calculated by the indirect method (Beral, 1974), using the
average age-specific rates for the entire period to derive the
expected values for each cohort. These cohort ratios are a
summary measure of the risk experience of each generation
for the ages included in the study period, relative to the same
ages for all cohorts included in the analysis, after adjusting
for differences in the age structure. Ninety-five per cent
confidence intervals for these ratios were estimated by using
approximate methods based on the normal distribution or,
when the number of cancers underlying these ratios was less
than 20, exact methods based on the binomial distribution.
Year of birth was known directly for all deaths and for
1971-87 cancer registrations. For cancer registrations before
1971 year of birth was not recorded, and we therefore esti-
mated it from year ofcancer incidence and single year ofage.
Population data were also not available by year of birth, so
we estimated these from data on the population by calendar
year and single year of age. For each age vs. calendar year
combination, two adjacent years of birth were possible. We
assumed that equal numbers of people were born in these
two years.
Childbearing variables for successive generations ofwomen
born in England and Wales were obtained from various
sources. Age-specific fertility rates for women born from
1874 to 1919 were calculated from cross-sectional data ex-
tracted from Registrar General (1947) and OPCS (1974). For
women born after 1919, cohort fertility rates were extracted
from OPCS (1992a,b). Average completed family sizes for
successive cohorts of women born before 1920 were cal-
culated from data on family size (General Register Office,
1960) and mean age at marriage (OPCS, 1972) for successive
marriage cohorts, adjusting for the proportion of women in
each cohort who remained single by age 40-44 (OPCS and
GRO for Scotland, 1993), and whom we considered as child-
less. (This assumption should not have affected the estimates
appreciably since more than 95% of the births that occurred
until the 1960s were legitimate; OPCS, 1978.) Average com-
pleted family size data for generations of women (irrespective
of marital status) born from 1920 onwards were extracted
from OPCS (1992a). Since the most recent cohorts were still
at childbearing ages, we also extracted from OPCS (1992a)
data on the family size achieved by the age of 30 for cohorts
born after 1920. Information on age at first birth for women
born since 1920 (the earliest cohort for which data are
available) were extracted from Werner and Chalk (1986).
Nulliparity by age 40 for successive cohorts born before 1930
was calculated from data on the proportion of childless
women and age at marriage for successive marriage cohorts
(Glass and Grebenik, 1954), adjusting for the proportion of
women who were still single by age 40-44 (OPCS and GRO
for Scotland, 1993) and whom we regarded as childless.
Nulliparity data for generations of women (irrespective of
marital status) born after 1920 were calculated from OPCS
(1992a). Statistics on oral contraceptive use were obtained
from Wiseman (1984), Royal College of General Practition-
ers (1986) and Thorogood and Vessey (1990).
Results
Cancer trends
During 1962-87, 529 282 cases of female breast cancer,
108 525 of ovarian cancer and 96 703 of endometrial cancer
were registered in England and Wales. These tumours were
responsible respectively for 353 229, 107 676 and 44 838
deaths in females during 1962-91.
There was a marked increase in the incidence rates of
female breast cancer during 1962-87 (0.95% increase per
annum; P<0.001), particularly at ages 45 and over (1.42%
per annum; P<0.001). At ages under 45, however, an in-
crease in incidence during the 1960s was followed by a
decline from the early 1970s onwards (Figure la). For
ovarian cancer, there was also an overall increase in inci-
dence from 1962 to 1987 (0.76% increase per annum; P<
V.;
I .I; , .!3
0.50.001), and again the incidence trends differed by age. At
ages 45 and over, there was a marked increase in rates
(1.32% per annum; P<0.001), whereas at ages 0-44 there
was a small decrease (-0.29% per annum; P=0.02). The
decline is now starting to reach older women (Figure lb).
Overall, the incidence ofendometrial cancer increased slightly
from 1962 to 1987 (0.13% per annum; P<0.002), but again
trends diverged by age. At ages 45 and over, there was a rise
in rates (0.62% per annum; P<0.001), whereas at ages under
45 there was a decrease (- 1.17% per annum; P<0.001)
(Figure Ic).
Mortality data showed patterns similar to those for inci-
dence (Figure 2). There was an overall increase in breast
cancer mortality from 1962 to 1991 (0.57% per annum;
P<0.001), but rates declined at young ages, particularly
from the late 1960s onwards (Figure 2a). Overall, there was
no change in mortality from ovarian cancer (0.14% per
annum; P= 0.65), but at young ages there were declines
which started at successively later periods at successively
older age groups (Figure 2b). The overall mortality from
endometrial cancer declined (- 1.01% per annum; P<0.001),
with declines at each age group (Figure 2c).
Figure 3 shows risks of breast, ovarian and endometrial
cancer incidence for successive generations of women born in
1875-1964 and their relationship with trends in family size.
For breast cancer an increase in risk occurred for successive
cohorts born after 1880-84, reaching a maximum for those
born in 1925-29 (SCRR = 106.7; 95% CI = 105.8-107.7).
Thereafter the risk decreased progressively, so that the risk
for women born in 1960-64 (SCRR = 74.6; 95% CI =
63.4-87.3) was about 30% lower than that for women born
in 1925-29. Analyses of 5 year age-specific rates by year of
birth also showed declines in the risk of breast cancer in all
age groups under 45 for cohorts born since 1925-29. For
ovarian cancer, the risk also increased for successive genera-
tions of women born after 1875-79, reaching a peak for
those born in 1925-29 (SCRR = 108.5; 95% CI = 106.3-
110.7). This rise was particularly marked for women born
before the turn of the century, and less pronounced for those
born between 1900-04 and 1925-29. Thereafter there was a
fall in risk, to a minimum for women born in 1940-44
(SCRR = 91.5; 95% CI = 87.6-95.5), then a high risk for the
cohort born in 1950-54 (SCRR = 107.7; 95% CI= 100.6-
115.3) and then a decline again. The pattern for endometrial
cancer was similar to that for ovarian cancer, except that
there was no peak in 1950-54 and the decline for the most
recent cohort (1960-64) was greater (SCRR = 59.6; 95%
CI = 35.9-93.1), but based on only 19 cases.
Mortality cohort trends (not shown) were similar to those
for incidence except that for endometrial cancer the mortality
risks started to decrease earlier than for incidence, and for
endometrial and ovarian cancers the decline over recent
cohorts was greater.
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1920 to 60% for women born in 1945. This increase was
paralleled by a slight increase in breast cancer risks. But since
the 1945 cohort breast cancer risks have continued to decline
despite the marked fall in the proportion of women having
their first child at young ages.
Figure 5 shows trends in fertility at young ages (as a proxy
for age at first birth, for which data were not available for
cohorts born before 1920), and in nulliparity by age 40, for
successive generations of women in relation to their breast
cancer risks. The general pattern was similar to those des-
cribed above for family size and age at first birth. There was
an inverse relationship between fertility and breast cancer
risks for women born before 1910 but the opposite for
a
4)
CD
N
Co 04
0 0 0.
0
0
0)
Cu
CD
CD
0
0
0.
0
0m Qc
CD
1.3
1.1
0.9
0.7
Age group (years)
_ 30-34
+ 40-44
* 50-54
- 060-64
X 70-74
il l
1962- 1967- 1972- 1977-
Year of death
C
I r. _
1982- 1987-91
Year of death
Trends infertility and relation with the cancer trends
Average completed family size fell from 3.3 children per
woman born in 1875 to 1.9 per woman born in 1910 (Figure
3). This decrease coincided with marked increases in the risks
of breast, ovarian and endometrial cancers (Figure 3). From
1920 onwards, however, family size increased from 2.0 for
women born in 1920 to 2.4 for those born in the mid-1930s,
accompanied by marked reductions in the risk of breast,
ovarian and endometrial cancers. Since the 1935 cohort,
family size has declined and, although the most recent
cohorts are still at childbearing ages, their family size
achieved by age 30 is lower than in previous cohorts (Figure
3). Cohort trends for the study cancers have been generally
downward in this period, although with interruption for
those born around 1950 for ovarian and endometrial cancers.
There were no close parallels between age at first birth and
breast cancer risks for generations born from 1920-24 (the
earliest cohort for which data are available) to 1960-64
(Figure 4). The proportion of women having their first child
at ages under 25 increased from 40% for women born in
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Figure 2 Mortality rates from breast (a), ovarian (b) and endo-
metrial (c) cancers in women at selected ages, expressed as pro-
portions of the corresponding 1962-66 rates. England and
Wales, 1962-87.
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women born subsequently: breast cancer risks rose for the
cohorts born in 1910-29 despite an increase in fertility, and
then declined during a period when fertility was generally
falling (Figure 5). Although there was a substantial increase
in the proportion of teenage mothers among females born in
the 1940s, these represented a small group of women and
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their contribution to the overall fertility at young ages was
outweighed by the declines in fertility at ages 20-29. There
were also no close parallels between breast cancer risks and
trends in nulliparity (Figure 5). The marked rises in the
cancer risks that occurred for those born before the turn of
the century were accompanied by little change in childless-
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Figure 3 Incidence trends of breast, ovarian and endometrial cancers in women aged 0-84 and family size, for cohorts born
1875-1964, England and Wales.
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Figure 4 Incidence trends of breast cancer in women aged 0-84 for cohorts born 1875-1964 and proportion of women having a
first child at young ages for cohorts born 1920-64. England and Wales.
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while breast cancer risks increased slightly. Nulliparity in-
creased for cohorts born in 1945/9-1955/9, whereas breast
cancer risks for these cohorts declined substantially. The
cohorts born since 1955-59 are still at childbearing ages, but
the proportion of women remaining childless at each age has
progressively risen (Coleman, 1993) while breast cancer risks
have diminished.
Trends in oral contraceptive use and relation with the cancer
trends
Oral contraceptives were introduced in the UK in 1960, and
their use grew rapidly thereafter. The cumulative proportions
of 'ever users' for successive generations of women rose from
about 40% for women born in the 1930s to about 70% for
women born in the 1940s and 80-90% for those born in the
1950s and 1960s (Figure 6). This increase was paralleled by
marked decreases in the risks of ovarian and endometrial
cancers and a lesser decrease for breast cancer.
In the earlier cohorts women started using the pill late in
their reproductive life, mainly for birth spacing after mar-
riage. Only in the most recent cohorts did the pill become a
popular method of contraception at young ages (Figure 6).
As a consequence, only in cohorts born after the 1930s were
there appreciable numbers of women who were exposed to
oral contraceptives early in life. The risk of breast cancer at
young ages (0-44 years) has decreased for women born since
the 1930s (Figure 7).
Discussion
The present study showed trends for ovarian, endometrial
and breast cancers, which were to different extents explicable
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by the well-established reproductive risk factors. Potential
artefacts and non-reproductive causes deserve consideration
as alternative explanations of the trends.
Completeness of cancer registration in England and Wales
probably improved somewhat before 1971, but has not alter-
ed appreciably since then (Swerdlow et al., 1993). Thus,
changing completeness of registration might in part have
been responsible for the rise in incidence of the study cancers
that occurred in the early years, but could not be the reason
for the declines in incidence more recently. Since mortality
data showed trends similar to those observed for incidence, it
is unlikely that the incidence results were seriously affected
by registration artefacts.
The use of exact data on year of birth (or its calculation
from single year of age and calendar time) makes these
cohort analyses more accurate than usual, by avoiding the
overlap of risks between generations that occurs when year
of birth is imprecisely estimated from 5 year data on age and
calendar time (Case, 1956). The method used to calculate the
cohort ratios tends, however, to underestimate real changes
because of the inevitable use of the overall data to generate
the expected values. Moreover, the most recent cohorts are
still too young to be definite about their long-term risk, and
their risks were in some instances based on relatively small
numbers.
The denominators used in the calculation of the cancer
rates (total female population at risk) might have been inap-
propriate if a large proportion of women had their breasts,
ovaries or uteri surgically removed. Alderson and Donnan
(1978) have shown that adjusting for trends in hysterectomy
did not affect significantly the denominator in the calculation
of cervical cancer trends in England and Wales, which sug-
gests that the same would be true for endometrial cancer.
Since oophorectomies were much less frequent than hysterec-
tomies during this period, and did not show any substantial
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Figure 5 Incidence trends of breast cancer in women aged 0-84, fertility rates at young ages and nulliparity rates by age 40, for
cohorts born 1875-1964, England and Wales.
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change in frequency as far as data are available (Department
of Health and Social Security and OPCS, 1970, 1981), it
seems unlikely that they distorted the ovarian cancer trends.
Radical mastectomies are performed too infrequently to have
accounted for the breast cancer trends. Organised screening
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programmes are available only for breast cancer, but in most
of the country they started after the study period (Chamber-
lain et al., 1993).
Other factors will have affected the trends presented here.
Age at menarche has declined at a rate of about 2-3 months
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Figure 6 Incidence trends of breast, ovarian and endometrial cancers and cumulative percentages of ever users of oral con-
traceptives in women aged 0-84, for cohorts born 1875-1964, England and Wales.
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per decade over the last 150 years (Wyshak and Frisch,
1982). There is some evidence that this downward trend has
been replaced by one in the opposite direction for cohorts
born since the late 1940s (Dann and Roberts, 1993). If real,
this increase in menarcheal age might have contributed to the
declines in the incidence of the study cancers for cohorts
born in the 1950s and 1960s. In contrast, and as far as data
are available, age at natural menopause seems to have re-
mained relatively constant since the last century (McKinlay
et al., 1972). The proportion of women who have an artificial
menopause has increased from about 1% for those born at
the turn of the century to about 5% for those born in the
1930s, but this change is too small to account for the recent
declines in the incidence of the study cancers.
Total energy intake and dietary fat have been found to be
associated with the risk of study cancers in population-based
studies, although the evidence from person-based studies has
been far from conclusive (Miller et at., 1994). Population
data on total energy intake and fat consumption over time
do not show close parallels with the cancer risks. Total
caloric intake and fat intake increased in England and Wales
from the turn of the century to the 1970s, except for a fall
during the Second World War (Greaves and Hollingsworth,
1966), and have decreased slightly since then. There has also
been a trend towards consumption of a greater proportion of
non-saturated fat (Buss, 1991). This fall in caloric and fat
intake and the replacement of saturated by unsaturated fat
might have contributed to the recent declines in the risk of
the study cancers.
Considering reproductive history, for ovarian cancer high
parity is one of the most important protective factors. Risk
decreases progressively with increasing numbers of children
(Booth, 1991) and is about 50% reduced for women with two
children (Hildreth et al., 1981). A marked increase in the risk
of ovarian cancer occurred for successive generations of
women born before the turn of the century, which paralleled
marked decreases in family size. The same effect has also
been seen in ovarian cancer mortality data for an earlier
period (Beral et al., 1978).
High parity is also an important protective factor against
endometrial cancer (Elwood et al., 1977; Henderson et al.,
1983). Women with two children have an 80% reduction in
risk compared with nulliparous women (Henderson et al.,
1983). Again, there were large increases in the risk of this
cancer in successive cohorts born before 1900. For women
born more recently the trends for ovarian and endometrial
cancers were not explicable by changes in parity. There was a
small rise in parity from 1.9 in 1920 to 2.4 in the mid-1930s,
which seems insufficient to account for the full decline in the
risks of these cancers. Besides, the risks continued to decrease
for cohorts born after the mid-1930s despite decreases in
parity. The progressive decreases in risks of endometrial and
ovarian cancers for successive generations of women born
from the 1920s to the 1940s do, however, parallel the intro-
duction and increasing use of oral contraceptives, and could
be explained by this. Studies have consistently shown a pro-
tective effect of pill use against epithelial ovarian cancer,
which becomes apparent with only 6 months' pill use. On
average, there is about a 50% reduction in risk, depending
on duration of use (Prentice and Thomas, 1987). Oral contra-
ceptives also protect against endometrial cancer. The protec-
tive effect appears after 12 months use, and there is a 60%
reduction in risk with 2 years of use and an 80% reduction
with more than 10 years of use (Henderson et al., 1983). The
decrease in the risks of these cancers at post-menopausal ages
observed in the present study is also consistent with the
long-lasting protective effects of oral contraceptive use, which
seem to persist for at least 15 years after cessation of use
(The Cancer and Steroid Hormone Study, 1987a,b). For
cohorts born after the 1940s, the incidence risks presented a
more irregular pattern, particularly for ovarian cancer, which
showed a peak in risk for women born in 1950-54. However,
these cohorts were still too young to be definite about their
long-term risks and a marked proportion of their ovarian
cancers were of germ cell origin (about 30% of ovarian
cancers of known histology at ages under 30 were of germ
cell origin in the present data set). The protective effect of
oral contraceptive use has only been shown for epithelial
ovarian cancers and its effect on other histological types is
not known.
The trends in breast cancer incidence and mortality are
more difficult to interpret. For women born before 1910-14,
decreases in fertility at young ages paralleled the increases in
breast cancer risks and may, at least in part, have been
responsible for them. For women born subsequently, how-
ever, this negative relationship was replaced by a positive
one. Breast cancer incidence increased for generations born
from 1910-14 to 1925-29 despite their increase in fertility at
young ages, and decreased steadily thereafter when the pro-
portion of women having their first child at young ages rose
but then declined.
The majority of studies have not shown any overall in-
crease in the risk of breast cancer for women who have ever
used oral contraceptives, even after a long duration of use
(Malone et al., 1993). Recent meta-analyses combining
results from practically all studies conducted to date (Romieu
et al., 1990; Thomas, 1991) were also reassuring. However,
studies of the effect of pill use at young ages have produced
confficting results. While some have been negative, others
have shown an increased risk ofpremenopausal breast cancer
for prolonged use of oral contraceptives at young ages (Ma-
lone et al., 1993). In their meta-analyses, Romieu et al. (1990)
and Thomas (1991) found a relative risk of about 1.5 for
prolonged use at ages under 45. The UK National Case-
Control Study showed a relative risk up to 1.7 for 8 years of
oral contraceptive use before age 36 (UK National Case-
Control Study Group, 1989). So far, cancer registration data
do not suggest that breast cancer incidence at young ages
might be increasing as a result of use of oral contraceptives -
indeed their risks to date are lower than those of previous
generations. Although an effect might be seen in the future,
particularly if the latent period is long, at present it is a
decrease not an increase in risk that needs explanation. It is
possible that changes in menarcheal age and dietary fat
intake might have been, at least in part, responsible for this
decline. It has also been suggested that, like pregnancy, oral
contraceptive use might have a biphasic effect on the subse-
quent risk of breast cancer - an early transitory adverse effect
and a long-term beneficial effect (Wingo et al., 1991; Beral
and Reeves, 1993). A reanalysis of data from the Cancer and
Steroid Hormone Study (Wingo et al., 1991) showed results
compatible with this hypothesis. The data presented here are
consistent with a long-term beneficial effect of oral con-
traceptive use on the risk of breast cancer, but further
individual-based studies are required to test this hypothesis.
The timing of the decline in breast cancer risks and the
parallels with ovarian and endometrial cancer trends are,
nevertheless, striking.
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Note added in proof
We have now received from OPCS breast cancer incidence data for
the years 1988-89. There was a sudden marked increase in the
number of breast cancer registrations in 1987 which affected all age
groups. This rise was restricted to the Thames Cancer Registry and it
might reflect better ascertainment of this Registry since its amal-
gamation with the north-west and north-east regions in 1985.Breast, ovarian and endometial cancertrends
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